Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from InhaleRx Limited ( (AU:IRX) ) is now available.
InhaleRx Limited reported a 15.8% increase in its half-year loss, amounting to $854,332 for the period ending June 30, 2025, compared to the previous year’s loss of $737,576. The company did not declare any dividends during this period, and its net tangible assets per ordinary security decreased significantly from (0.03) cents to (0.41) cents, indicating a challenging financial performance.
More about InhaleRx Limited
InhaleRx Limited operates in the healthcare industry, focusing on the development and provision of inhalation-based therapies. The company is dedicated to advancing medical treatments through innovative inhalation technologies.
Average Trading Volume: 267,657
Technical Sentiment Signal: Buy
Current Market Cap: A$7.47M
Learn more about IRX stock on TipRanks’ Stock Analysis page.